. Lipid barrier of the skin was largely impaired after Isopropyl mirystate treatment
INTRODUCTION
Although the stratum corneum owes its barrier properties largely to its intercellular lipid, it cannot be regarded as a simple lipid membrane due to its special composition and microstructure (Elias et al., 1977) . It has been increasingly recognized that understanding the structure and function of the stratum corneum (SC) is essential for achieving effective transdermal drug delivery. For the last 40 or so years, transdermal delivery of drug molecules has been extensively studied. However, only about 20 drug molecules have been formulated successfully as transdermal products, due to the barrier property of SC (Subedi et al., 2010) . In order to modify the SC and to increase the permeability, various methods have been developed, including chemical penetration enhancers, prodrugs, iontophoresis, electroporation, sonophoresis and microneedles (Ibrahim et al., 2010; Kigasawa et al., 2010) . Among these methods, the simplest way to enhance the skin penetration of drug without any extra device is to incorporate the chemical enhancers into the formulation.
Various hydrophilic and hydrophobic chemicals have been studied for their capability as the skin penetration enhancer and their mechanisms of action have been reported. Lipid extraction and osmotic swelling are reported to be the main reason for the enhancement effect of ethanol (Rastogi et al., In this work, we have investigated the effect of polyoxyethylene alkyl ester nonionic surfactants on percutaneous permeation enhancement of a model drug, ketoprofen. We also investigated the mechanism involved in the enhancement using impedance and solubility measurement. Three groups of nonionic surfactants with different ethylene oxide content were studied. The permeation results showed that all surfactants enhanced the percutaneous absorption, irrespective of the molecular weight. The permeation results from PEG-45 monostearate (PEGMS45) were rather unexpected. Impedance and solubility results indicate that the mechanism involved in the enhancement of permeation by PEG-10 monooleate (PEGMO10) and PEGMS45 is rather different. The results from PEGMS45 suggest that it could be a potential candidate as a skin penetration enhancer with high molecular weight, which may poses less skin irritation and systemic side effect than the smaller surfactant molecules. Overall, this work provided some useful information on percutaneous transport enhancement and the mechanistic insights involved in skin permeation for these nonionic surfactants.
DOI: 10.4062/biomolther.2011.19.1.109 enhancement of a model drug, ketoprofen, and to get more mechanistic insights on the permeation enhancement. Three groups of chemically related nonionic surfactants, which are derivatives of lauric acid (LA), stearic acid and OA with different ethylene oxide content, giving differences in hydrophilicity and molecular weight, were studied. The effect on electrical properties of skin was examined for these nonionic surfactants, in order to provide some mechanistic insights into the penetration enhancement through skin. We also have examined the solubility of ketoprofen in various vehicle solutions containing nonionic surfactants and the result was used in combination with the impedance data for the interpretation of permeation results. Skin permeation study for OA and LA were also carried out for comparison.
Nonionic surfactants are widely used in dermal formulations, primarily as stabilizers (Bárány et al., 2000) . These are polysorbates (ethoxylated esters, partial esters of sorbitol), polyoxyethylene alkyl ethers, polyoxyethylene alkyl esters, polyoxyethylene alkylphenols, and poloxamers (polyoxyehylene-polyoxypropylene block copolymers). It is thought that these surfactants are mild on the skin even at high loadings and long-term exposure. Their effect on skin permeability has been determined for only a small number of drugs so far (Park et al., 2000) and not much efforts have been made about their direct effects on the lipid of the SC.
Electrically, skin is usually represented as a parallel combination of capacitance (C) and resistance (R) (Yamamoto and Yamamoto, 1976) . From the stripping experiments, it has been shown that the SC is mainly responsible for the electrical properties of the skin. The capacitance of the skin is thought to originate from the lipid matrix-keratin cell complex, while the resistance appears to be primarily associated with the current fl owing pores (Oh et al., 1993) . These pores are mainly locating at appendages on skin, such as hair follicles and sweat glands, though there are some unidentifi ed pathways whose contribution to the fl ow of current is dependent on the magnitude of current (Cullander and Guy, 1991) . Electrical impedance (Z) measurements have shown that R and/or C may be affected by various factors such as hydration, ionic strength of the skin-bathing medium, pH and chemical treatment (Oh and Guy, 1993) . The effect of iontophoresis on R and C has also been studied (Oh and Guy, 1995) . It has also been shown that skin permeability is closely related to the electrical resistance of skin (Burnette and Bagniefski, 1988) .
MATERIALS AND METHODS

Materials
All reagents and chemicals were of the highest commercially obtainable purity. Nonionic surfactants containing ethylene oxide (EO) of various average chain lengths were obtained from Nikko Chemicals Co. (PEG-10 monooleate (PEGMO10), PEG-10 monolaurate (PEGML10), PEG-10 monostearate (PEGMS10), PEG-25 monostearate (PEGMS25), PEG-45 monostearate (PEGMS45)) and Sigma Chemical Co. (PEGmonolaurate 400 (PEGML4), PEG-monooleate 460 (PEG-MO4)). OA and LA were purchased from Junsei Chemicals (Tokyo, Japan) and Sigma Aldrich (Seoul, Korea). Chemical structures of these molecules are given in Fig. 1 . Sodium phosphate monobasic and HEPES (N-[2-hydroxy-ethyl]-piperasine-n'-12-ethane sulfonic acid) were also purchased from Sigma-Aldrich Co. (Seoul, Korea). Propylene glycol, acetonitrile (HPLC grade) and sodium chloride were obtained from Duksan Chem. (Seoul, Korea). Distilled water was prepared using Barnstead Nanopure ultrapure water system D11921 (Dubuque, Iowa, USA). Ketoprofen was provided by Wha-il Chemicals Co. (Ansan, Korea).
Solubility measurement
Excess amount of ketoprofen was added to the vehicle solution (propylene glycol:water=2:1, v/v), in which the enhancer is dissolved. After equilibration for 24 hours at 37 o C with shaking, the suspension was centrifuged at 5,000 rpm for 5min, and the supernatant was diluted with distilled water. The assay of ketoprofen was carried out using a HPLC, as described below.
Skin permeation
All surfactant molecules (PEGMLs, PEGMOs and PEGMSs) and fatty acids (OA and LA) were investigated for their ability as penetration enhancers. The effect of concentration and molecular weight on fl ux was studied. Ketoprofen transport experiments were made using full-thickness hairless mouse skin. The skin was excised and frozen immediately after sacrifi ce of 8-12 week old mouse (Yonsei university lab. Animal center, Seoul, Korea). It was stored at −70 o C and then thawed just before use. A side-by-side diffusion cell (Yuil Science, Pusan, Korea) was used. The chamber held a volume of 1ml and was magnetically stirred. The area of skin exposed to each chamber was 0.5 cm 2 . The donor and receptor chamber were fi lled with PG/water (2:1) solution containing ketoprofen (saturated) and HEPES buffer saline (pH 7.4), respectively. Each enhancer was dissolved in the donor solution. At a predetermined time interval, sampling was made and an equal volume of 1 ml HEPES buffered saline (133 mM) at pH 7.4 was added to the receptor chamber. Multistirrer Electronicrührer Poly 15 (Variamag, München, Germany) was used for constant stirring of the solutions. Experiments were conducted at 37 o C using an incubator (Jeio Tech, SI-900, Ansan, Korea). 
Drug assay
To assay ketoprofen, a high performance liquid chromatograph was employed (Shimadzu LC 10AS). The chromatograph was equipped with an automatic sampler injector (Shimadzu SIL-10A), a variable wavelength UV detector (SPD-10A) and a reversed phase column (KR100-10018, 4.6×250 mm, Kromasil, Bohus, Sweden). The column temperature was maintained at 30 o C. The mobile phase was acetonitrile:phosphate buffer (pH=3), 50:50. The UV detection was at other 258 nm, with a fl ow rate 1 ml/min.
Preparation of electrodes
Ag/AgCl electrodes were used for their stability and reversibility. Two types of electrodes were prepared. The rodshaped electrodes were prepared by dipping the tip of an Ag wire (99.9%, Aldrich, Milwaukee, WI) (1 mm diameter) into the molten AgCl. The plate-shaped electrodes were prepared electrochemically. Ag plate (2×2 cm, 1 mm thickness) was lightly sanded with emery paper, washed in a acetone, and then cleaned in 1M HCl for 20 min at 50 o C. After rinsing with distilled water, the Ag was anodically plated with AgCl (using a Pt cathode) by immersion in 1M KCl and application of a 0.5 mA current for 24 h.
Diff usion cell
A side-by-side, two chamber diffusion cell with four electrode inlets (two for signal electrodes and two for sensing electrodes) was designed and made by Yuil Science (Pusan Korea) Inlets in the diffusion cell permitted the positioning of signal electrodes and sensing electrodes on either side of the skin.
Impedance measurements and data analysis
All solutions for impedance experiments were prepared with distilled water from a nanopure water system (Barnstead).
Skin impedance measurements were made using full-thickness hairless mouse skin, excised and frozen immediately after sacrifi ce of 8-week-old mouse. It was stored at −70 o C and then thawed just before use. Fig. 2 shows the experimental setup of impedance measurements. The donor and receptor chamber were fi lled with PG/water (2:1) solution containing enhancer and HEPES buffer saline (pH 7.4), respectively. The electric circuit employed for the impedance measurements included a 2 MΩ resistor in series with the skin. At an applied voltage of 2 V (peak-to-peak), a sinusoidal current was applied via a signal generator (FG-7002C, LG Precision Co., Seoul, Korea) to the signal electrode on the epidermal side of the skin (the dermal-side electrode was grounded). Since the SC impedance (Z) was routinely 100 KΩ or less, the current was determined primarily by the 2 MΩ resistor in series. The current was therefore can be treated as constant value at all frequencies examined. The potential difference across the skin was then determined by measuring the voltage at each sensing electrode using a digital oscilloscope (OS-902RB, LG Precision Co., Seoul, Korea). The potential difference was evaluated over the frequency (f) range of 1-100 KHz, with fi ve frequency points per decade. Each frequency sweep required about 10 min.
Preliminary experiments with skin replacing the model RCcircuit demonstrated that the medium bathing the tissue contributed negligible to the potential drop detected between the sensing electrodes. Data from subsequent experiments using skin were analyzed in the frequency range (0.1-5.0) · f Xc Hz, where f Xc is the so-called 'corner' frequency, at which the imaginary component of complex impedance is maximum (as determined in the Cole-Cole plot (36)) and the capacitive effect is most infl uential. An initial estimate of f Xc was calculated from the equation f Xc =1/2πRC, values of R and C having been derived from the 10 Hz impedance and the slope of the 1/Z 2 vs. f 2 plot. Because the skin cannot be a perfect RC circuit, and shows rather depressed semi-circle, we used low frequency impedance value at 10 Hz as the R value, instead of calculating from the intercept of the 1/Z 2 vs. f 2 plot. In this way, the frequency range of subsequent 1/Z 2 vs. f 2 plots was narrowed, eliminating high frequency data points for which determination of impedance becomes very diffi cult due to the very small voltages being measured under these conditions.
RESULTS
Skin permeation
Nonionic surfactants are commonly used emulsifi ers in medicinal and cosmetic formulations. The main components used as nonionic surfactants are the Tween, SPAN and the Brij series. They are known to have enhancing effects on the permeability of biological membranes, including skin (Va Hal et al., 1996) . Their comparatively low toxicity and irritation potential make these compounds good candidates as potential penetration enhancers for use in transdermal drug delivery systems. In this work, we have studied 7 kinds of polyethylene glycol alkyl esters for their percutaneous fl ux enhancement ability and the results are compared. These are PEGML4, PEGMO4, PEGML10, PEGMO10, PEGMS10, PEGMS25 and PEGMS45 (Fig. 1) . Fatty acids such as OA and LA were also studied. Fig. 3 shows the effect of PEGML on the cumulative amount of ketoprofen transported across skin as a function of concentration. Cumulative amount transported for 24 hours (CAT 24 ) increased by the application of PEGMLs, and the increase were concentration dependent (p<0.05). When 5 % (v/v) of PEGML4 was used, CAT 24 was 7.9 mg/cm 2 , which is about 2.6 fold larger than the CAT 24 obtained without PEGML4 (3.0 mg/cm 2 ). For 5% PEGML10, the increase in CAT 24 was 2.4 fold, and was smaller than that for PEGML4 (p<0.05). Similar tendency was observed for PEGMO (Fig. 4) . Fig. 5 shows the permeation results of PEGMS10, PEGMS25 and PEGMS45. When compared to control, CAT 24 increased by the application of PEGMSs at all concentration. For 5% (v/v) PEGMS10, CAT 24 was 6.1 mg/cm 2 , and it decreased to 4.7 mg/cm 2 when PEGMS25 was used. PEGMS45, which has the longest polyethylene oxide chain, showed similar value (4.7 mg/cm 2 ) to PEGMS25 at 5%. PEGMS45 showed slightly higher CAT 24 (5.4 mg/cm 2 ) at 1% concentration than 5%, though not signifi cant (p>0.05). The comparison for permeation enhancement among these nonionic surfactants is shown in Fig. 6 . Both PEGML and PEGMS showed higher 
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In this work, we also carried out in vitro fl ux study of lauric and OA without PEG chain for comparison. Fig. 7 shows the permeation profi les of ketoprofen through the skin, these fatty acids are used as penetration enhancers. Stearic acid was not completely dissolved in the donor solution and, hence, penetration experiment could not be carried out. Transport across the skin increased as the concentration of these acids increased (p<0.05). 5% LA showed higher enhancing effect than 5 % OA (p<0.05), however, it was not signifi cant at 1% concentration (p>0.05).
Skin impedance
Electrically, skin is usually represented as a parallel combination of C and R (Yamamoto and Yamamoto, 1976) . The C of the skin is thought to originate from the lipid matrix-keratin cell complex, while the R appears to be primarily associated with the current conducting pathways (Oh et al., 1993; Burnette and Bagniefski, 1988) . It has also been shown that skin permeability is inversely related to the electrical resistance of skin (Burnette and Bagniefski, 1988) . In this work, we have inves- 
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tigated the effect of PEG nonionic surfactant on the electrical properties using impedance spectroscopy. Z is measured as a function of frequency and Bode plot is constructed. Electrical resistance and capacitance (C) are calculated and the results are used in the interpretation of the permeation results described above. Fig. 8 shows the Bode plot of skin impedance as a function of frequency with time for 24 hours in bathing solutions of control, PEGMO10 and PEGMS45. For comparison, the Bode plot obtained from skin bathing in pH 7.4 buffer is also shown. In all cases, the impedance profi le with frequency was similar to the typical parallel RC circuit. At low frequency, impedance changed slightly with time, but as the frequency increased, rapid drop in Z occurred due to the conductive role of the capacitor part of the skin. At high frequency, capacitor part of the skin becomes transparent and Z is essentially constant and time-independent. The drop in Z at low frequency with time is small for pH 7.4 buffer solution, however, it was slightly larger for control solution and PEGMS45, and large drop was observed for PEGMO10. Fig. 9 shows the change in R and C of skin with time for PEGMO10 and PEGMS45 treated skin. For control skin, which was immersed in PG/water (2:1) solution, R decreased slowly with time, and after 24 hours, it reached 32% of initial R value. PEGMO10 decreased the R rapidly and after 24 hours, R was only 5% of the initial value. However, for PEGMS45, the decrease in R with time was much slower than that observed for PEGMO10 and was similar to control skin. Contrary to electrical resistance, C increased in all cases. For control skin, the increase in C with time was slow, and C reached 144 % of initial C value. PEGMO10 increased C more rapidly, and it increased more than two fold after 24 hours. However, for PEGMS45, C increased very slowly and it increased only up to 125% of initial C after 24 hours.
DISCUSSION
The permeation results from PEGMS45 were rather unexpected, because we expected that, as the length of the polyethylene oxide chain increases, it would be harder to penetrate into the stratum corneum lipid to increase the fl ux. Especially, when we think of the molecular weight of PEGMS45, which is about 2,300, it seems diffi cult for this surfactant to penetrate into the lipid domain. Except for PEGMS25 (Mw: about 1,400), the molecular weight of all the other surfactants used are in between 720 and 370. These molecules seem to be able to partition into the stratum corneum, and perturb the lipid structure.
The permeation results from fatty acid are in good agreement with the results from naloxone permeation or TEWL (transepidermal water loss) after different fatty acid treatment. Naloxone skin permeation study showed that permeation through skin increased as the carbon number in saturated fatty acid increases from 7 to 12 (LA) (Aungst et al., 1986) . However, it decreased as the carbon number increased further. This parabolic type permeation enhancing effect in fatty acid series was also reported in other studies using testosterone (Yu et al., 1991) . Similar results were reported in the study of skin barrier property impairment, using TEWL. TEWL Table 1 . Solubility increased after treatment with nonanoic acid (9 carbon), and it further increased with undecanoic acid (11 carbon), however it decreased for myristic acid (14 carbon), below the level of control (Kandimalla et al., 1999) . The fatty acid results show that low molecular weight PEG ester of lauric or OA (PEGML4 and PEGMO4) exhibited higher permeation enhancing effect than fatty acid itself. For 5% PEGML4 and PEGMO4 treatment, CAT24 were 7.9 mg/cm 2 and 6.5 mg/cm 2 , respectively. For 5% LA and OA treatment, CAT24 were 6.8 mg/cm 2 and 4.7 mg/cm 2 , respectively. Similar result was obtained for 1% treatment. However, for PEGML10 and PEGMO10, CAT 24 values were similar to those obtained for free fatty acids.
Impedance results indicate that the mechanism involved in the enhancement of permeation by PEGMO10 and PEGMS45 is quite different. DSC and FT-IR study revealed that fl ux enhancement by LA was due to the increased fl uidity of the lipid domain in SC (Aungst, 1989) . Increased fl uidity of the lipid domain may enhance the hydration of SC, and thus increase the C and decrease the R. For PEGMO10, there was a large change in R and C, suggesting that PEGMO10 actually absorbed into the SC and thus disrupted the lipid structure of the inter-corneocyte domain and current conducting pathways. However, for PEGMS45, the change in R and C was minimal and was similar to the values obtained for control experiment, suggesting the possibility that PEGMS45 may not penetrate into the SC. This is highly probable, because the molecular weight of PEGMS45 is about 2300, and PEGMS45 is not expected to diffuse into the SC.
The electrical property data of PEGMS45 make it diffi cult to provide simple explanation for the skin permeation results. Compared to PG/water solution (control), CAT 24 increased nearly two fold after 1% PEGMS45 treatment. CAT 24 for PEGMS45 was comparable to that of PEGMO10. These results suggest that the ability to enhance skin absorption is similar, despite of the smaller decrease in electrical resistance (Fig. 9) , which is known to be inversely related to the skin permeability. One possible speculation is the adsorption of the polymeric enhancer on the SC, and form a layer at the surface to increase the partition coeffi cient of ketoprofen to the skin surface, which resulted in the enhanced ketoprofen permeation through the skin (Akimoto et al., 2001) .
The other point to consider is the change in solubility of ketoprofen in the vehicle by the PEG surfactants. Transdermal permeation of drug molecules can be described by the equation, J=DKC s /h, where D is diffusion coeffi cient, K is the partition coeffi cient, Cs is the solubility and h is the thickness of the membrane (skin). The increase in permeation can be achieved by the increase in D, K and/or C s . D can be altered, when the stratum corneum lipid structure between the corneocyte is disrupted by the incorporation of permeation enhancer molecules. K is determined by the solubility difference between the donor solution and the skin. This means there is a delicate balance between C s and K, in their role for the enhancing effect; as the solubility in the vehicle increases, K decreases. In this work, the solubility of ketoprofen in the donor solution in the absence and presence of the enhancers are carried out, and the results are listed in Table 1 , together with the ratio of solubility in donor solution to that in control solution. For small nonionic surfactants with a PEG length less than 10, the solubility ratio was less than one in nearly all cases, suggesting that permeation enhancing effect of these surfactants is possibly from an increase in K. The increase in D may also contribute to the permeation enhancing effect due to the disruption of lipid structure by these small molecules, as observed in R & C change after PEGMO10 treatment (Fig. 9) . For larger nonionic surfactants like PEGMS45, the solubility ratio was larger than one at 5 % concentration. Considering the molecular size and the results in Fig. 9 about the change in R and C after PEGMS45 treatment, the permeation enhancing effect for PEGMS45 seems not the change in D,
The results from PEGMS45 suggest that it can be a good candidate as a skin penetration enhancer with minimal toxicity, because it may interact with SC minimally and probably not absorbed into the SC lipid domain. Frequent problems with a large number of conventional chemical permeation enhancers are side effects such as skin irritation, allergic reaction and unwanted absorption into the systemic circulation. In literature, various polymeric or oligomeric permeation enhancers have been reported (Aoyagi et al., 1991; Akimoto et al., 2001 ). Aoyagi et al. synthesized hexadecylpyridinium bromide-type polymers and their permeation enhancing activity on drug penetration was evaluated. Using 5-FU as the model drug for in-vitro permeation study, they showed 2-8 times increase in permeability without any irritation of the skin. They also studied the mechanism using differential scanning calorimetry and concluded that, although the polymeric enhancer interacted with the lipids and proteins of the lipids of the SC, it may not penetrate into deeper layers of the skin. Enhancing ability of polyethylene glycol or polydimethylsiloxane block copolymer with a cationic end-group was also demonstrated (Akimoto et al., 2001) . They demonstrated that the chain lengths of both the PEG and PDMS segments are important and suggested that the mechanism of action was an increase in the partition coeffi cient, rather than a change in the diffusion coeffi cient through the skin. They also demonstrated the absence of irritation by the application of these polymeric enhancers.
